OPRX NASDAQ
OptimizeRx Corp.
1W: -8.3%
1M: +3.5%
3M: +38.1%
YTD: -41.3%
1Y: -58.5%
3Y: -15.3%
5Y: -89.5%
$7.29
+0.11 (+1.53%)
Weekly Expected Move ±4.8%
$7
$7
$7
$8
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$136.8M
52W Range4.54-22.25
Volume115,204
Avg Volume357,124
Beta1.09
Dividend—
Analyst Ratings
Company Info
CEOStephen L. Silvestro
Employees133
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2007-11-28
Websiteoptimizerx.com
260 Charles Street
Waltham, MA 02453
US
Waltham, MA 02453
US
248 651 6568
About OptimizeRx Corp.
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Latest News
AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
Dimensional Fund Advisors LP Purchases 102,661 Shares of OptimizeRx Corp. $OPRX
OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| D'Silva Andrew J. | F-InKind | 1,432 | $7.86 | 2026-09-01 |
| D'Silva Andrew J. | F-InKind | 1,243 | $7.71 | 2026-08-21 |
| Stelmakh Edward | F-InKind | 1,381 | $7.71 | 2026-08-21 |
| Merrell Brendan W. | F-InKind | 1,020 | $7.71 | 2026-08-21 |
| Silvestro Stephen L | F-InKind | 1,737 | $7.71 | 2026-08-21 |